ANDREW PALENO: Open Payments
NPI 1891264438 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,087 in 92 payments from 13 companies in 2025. Trend: 2023 $899 · 2024 $576 · 2025 $2,087
Food & beverage: $2,087
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $421 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $381 |
| ABBVIE INC. | 19 | $368 |
| Otsuka America Pharmaceutical, Inc. | 7 | $204 |
| Axsome Therapeutics, Inc. | 10 | $186 |
| Lundbeck LLC | 6 | $129 |
| Alkermes, Inc. | 8 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $93 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
Products named: SPRAVATO, CAPLYTA, VRAYLAR, REXULTI, Auvelity, ARISTADA, TRINTELLIX, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
